- Record: found
- Abstract: not found
- Article: not found
LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study
T. Mazard ,
F. Ghiringhelli ,
A. Winter ,
C. de la Fouchardiere ,
D. Botsen ,
T. André ,
J. Vanbockstael ,
M. Dos Santos ,
J. Martin-Babau ,
Y. Rinaldi ,
L. Evesque ,
S. Ellis ,
C. Gavoille ,
D. Smith ,
M. Fonck ,
D. Sefrioui ,
V. Pezzella ,
S. Nougaret ,
A.R. Thierry ,
O. Bouche
October 2023
October 2023
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.